HbA1c Test Underestimates Glucose Control in Hemodialysis Patients
|
By Labmedica staff writers Posted on 25 Feb 2008 |
|
The standard hemoglobin A1c test (HbA1c) for estimating blood sugar control in people with diabetes is not accurate in those undergoing kidney hemodialysis.
HbA1c measures the percentage of hemoglobin (a protein in erythrocytes) that has reacted with glucose. This measure, also known as glycosylated hemoglobin, generally reflects blood sugar control over the previous 30-120 days.
A study, performed by researchers at Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA), evaluated the HbA1c test 307 patients with diabetes, 258 with end-stage kidney disease on hemodialysis, and 49 who did not have kidney failure. The standard HbA1c test was compared with a newer test (glycated albumin [GA]), which measures the amount of blood sugar that has reacted with albumin, a protein in the plasma. The GA test reflects blood sugar control over the previous three to four weeks. Blood samples were also analyzed to determine recent blood sugar levels.
Compared to those without kidney failure, diabetic patients on hemodialysis had higher blood sugars and GA levels, despite lower HbA1c results. The relationship between GA and HbA1c differed between diabetic dialysis patients and those without kidney disease, indicating that the HbA1c did not accurately reflect blood sugar control in those on hemodialysis.
The major reason for the discrepancy appears to be that HbA1c depends on erythrocyte survival and these cells do not live as long in hemodialysis patients. Most dialysis patients have anemia requiring treatment with medications that stimulate erythrocyte production (erythropoietin).
Controlling blood sugar is important because high levels are risk factors for developing atherosclerosis and lead to higher rates of kidney disease, heart attack, stroke, nerve damage, and blindness. People with diabetes who undergo hemodialysis are especially at high risk. About one out of four diabetic dialysis patients (23%) in the United States will die from cardiovascular and infection complications during their first year on dialysis, and only 31% survive five years.
Related Links:
Wake Forest University Baptist Medical Center
HbA1c measures the percentage of hemoglobin (a protein in erythrocytes) that has reacted with glucose. This measure, also known as glycosylated hemoglobin, generally reflects blood sugar control over the previous 30-120 days.
A study, performed by researchers at Wake Forest University Baptist Medical Center (Winston-Salem, NC, USA), evaluated the HbA1c test 307 patients with diabetes, 258 with end-stage kidney disease on hemodialysis, and 49 who did not have kidney failure. The standard HbA1c test was compared with a newer test (glycated albumin [GA]), which measures the amount of blood sugar that has reacted with albumin, a protein in the plasma. The GA test reflects blood sugar control over the previous three to four weeks. Blood samples were also analyzed to determine recent blood sugar levels.
Compared to those without kidney failure, diabetic patients on hemodialysis had higher blood sugars and GA levels, despite lower HbA1c results. The relationship between GA and HbA1c differed between diabetic dialysis patients and those without kidney disease, indicating that the HbA1c did not accurately reflect blood sugar control in those on hemodialysis.
The major reason for the discrepancy appears to be that HbA1c depends on erythrocyte survival and these cells do not live as long in hemodialysis patients. Most dialysis patients have anemia requiring treatment with medications that stimulate erythrocyte production (erythropoietin).
Controlling blood sugar is important because high levels are risk factors for developing atherosclerosis and lead to higher rates of kidney disease, heart attack, stroke, nerve damage, and blindness. People with diabetes who undergo hemodialysis are especially at high risk. About one out of four diabetic dialysis patients (23%) in the United States will die from cardiovascular and infection complications during their first year on dialysis, and only 31% survive five years.
Related Links:
Wake Forest University Baptist Medical Center
Gold Member
Fully Automated Cell Density/Viability Analyzer
BioProfile FAST CDV
New
Binocular Laboratory LED Illuminated Microscope
HumaScope Classic LED
New
Malaria Test
STANDARD Q Malaria P.f/Pan Ag
Latest Clinical Chem. News
- Carbon Nanotubes Help Build Highly Accurate Sensors for Continuous Health Monitoring
- Paper-Based Device Boosts HIV Test Accuracy from Dried Blood Samples
- AI-Powered Raman Spectroscopy Method Enables Rapid Drug Detection in Blood
- Novel LC-MS/MS Assay Detects Low Creatinine in Sweat and Saliva
- Biosensing Technology Breakthrough Paves Way for New Methods of Early Disease Detection
- New Saliva Test Rapidly Identifies Paracetamol Overdose
- POC Saliva Testing Device Predicts Heart Failure in 15 Minutes
- Screening Tool Detects Multiple Health Conditions from Single Blood Drop
- Integrated Chemistry and Immunoassay Analyzer with Extensive Assay Menu Offers Flexibility, Scalability and Data Commutability
- Rapid Drug Test to Improve Treatment for Patients Presenting to Hospital
- AI Model Detects Cancer at Lightning Speed through Sugar Analyses
- First-Ever Blood-Powered Chip Offers Real-Time Health Monitoring
- New ADLM Guidance Provides Expert Recommendations on Clinical Testing For Respiratory Viral Infections
- 3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models
- POC Biomedical Test Spins Water Droplet Using Sound Waves for Cancer Detection
- Highly Reliable Cell-Based Assay Enables Accurate Diagnosis of Endocrine Diseases
Channels
Molecular Diagnostics
view channel
Novel Point-of-Care Technology Delivers Accurate HIV Results in Minutes
HIV diagnostic methods have traditionally relied on detecting HIV-specific antibodies, which typically appear weeks after infection. This delayed detection has hindered early diagnosis, complicating patient... Read more
Blood Test Rules Out Future Dementia Risk
Previous studies have suggested that specific biomarkers, such as tau217, Neurofilament Light (NfL), and Glial Fibrillary Acidic Protein (GFAP), may be valuable for early dementia diagnosis.... Read more
Hematology
view channel
New Scoring System Predicts Risk of Developing Cancer from Common Blood Disorder
Clonal cytopenia of undetermined significance (CCUS) is a blood disorder commonly found in older adults, characterized by mutations in blood cells and a low blood count, but without any obvious cause or... Read more
Non-Invasive Prenatal Test for Fetal RhD Status Demonstrates 100% Accuracy
In the United States, approximately 15% of pregnant individuals are RhD-negative. However, in about 40% of these cases, the fetus is also RhD-negative, making the administration of RhoGAM unnecessary.... Read more
Immunology
view channel
Stem Cell Test Predicts Treatment Outcome for Patients with Platinum-Resistant Ovarian Cancer
Epithelial ovarian cancer frequently responds to chemotherapy initially, but eventually, the tumor develops resistance to the therapy, leading to regrowth. This resistance is partially due to the activation... Read more
Machine Learning-Enabled Blood Test Predicts Immunotherapy Response in Lymphoma Patients
Chimeric antigen receptor (CAR) T-cell therapy has emerged as one of the most promising recent developments in the treatment of blood cancers. However, over half of non-Hodgkin lymphoma (NHL) patients... Read more
Microbiology
view channel
New AI-Based Method Improves Diagnosis of Drug-Resistant Infections
Drug-resistant infections, particularly those caused by deadly bacteria like tuberculosis and staphylococcus, are rapidly emerging as a global health emergency. These infections are more difficult to treat,... Read more
Breakthrough Diagnostic Technology Identifies Bacterial Infections with Almost 100% Accuracy within Three Hours
Rapid and precise identification of pathogenic microbes in patient samples is essential for the effective treatment of acute infectious diseases, such as sepsis. The fluorescence in situ hybridization... Read more
Innovative ID/AST System to Help Diagnose Infectious Diseases and Combat AMR
Each year, 11 million people across the world die of sepsis out of which 1.3 million deaths are due to antibiotic-resistant bacteria. The burden of antimicrobial resistance (AMR) continues to weigh heavily,... Read more
Gastrointestinal Panel Delivers Rapid Detection of Five Common Bacterial Pathogens for Outpatient Use
Acute infectious gastroenteritis results in approximately 179 million cases each year in the United States, leading to a significant number of outpatient visits and hospitalizations. To address this, a... Read morePathology
view channel
AI Model Predicts Patient Response to Bladder Cancer Treatment
Each year in the United States, around 81,000 new cases of bladder cancer are diagnosed, leading to approximately 17,000 deaths annually. Muscle-invasive bladder cancer (MIBC) is a severe form of bladder... Read more
New Laser-Based Method to Accelerate Cancer Diagnosis
Researchers have developed a method to improve cancer diagnostics and other diseases. Collagen, a key structural protein, plays various roles in cell activity. A novel multidisciplinary study published... Read more
New AI Model Predicts Gene Variants’ Effects on Specific Diseases
In recent years, artificial intelligence (AI) has greatly enhanced our ability to identify a vast number of genetic variants in increasingly larger populations. However, up to half of these variants are... Read more
Powerful AI Tool Diagnoses Coeliac Disease from Biopsy Images with Over 97% Accuracy
Coeliac disease is an autoimmune disorder triggered by the consumption of gluten, causing symptoms such as stomach cramps, diarrhea, skin rashes, weight loss, fatigue, and anemia. Due to the wide variation... Read moreTechnology
view channel
Innovative, Label-Free Ratiometric Fluorosensor Enables More Sensitive Viral RNA Detection
Viruses present a major global health risk, as demonstrated by recent pandemics, making early detection and identification essential for preventing new outbreaks. While traditional detection methods are... Read more
Smartphones Could Diagnose Diseases Using Infrared Scans
Rapid advancements in technology may soon make it possible for individuals to bypass invasive medical procedures by simply uploading a screenshot of their lab results from their phone directly to their doctor.... Read more
Novel Sensor Technology to Enable Early Diagnoses of Metabolic and Cardiovascular Disorders
Metabolites are critical compounds that fuel life's essential functions, playing a key role in producing energy, regulating cellular activities, and maintaining the balance of bodily systems.... Read more
3D Printing Breakthrough Enables Large Scale Development of Tiny Microfluidic Devices
Microfluidic devices are diagnostic systems capable of analyzing small volumes of materials with precision and speed. These devices are used in a variety of applications, including cancer cell analysis,... Read moreIndustry
view channel
Grifols and Tecan’s IBL Collaborate on Advanced Biomarker Panels
Grifols (Barcelona, Spain), one of the world’s leading producers of plasma-derived medicines and innovative diagnostic solutions, is expanding its offer in clinical diagnostics through a strategic partnership... Read more
